SHANGHAI, China, May 13, 2025 – As it celebrates its 30th anniversary, Edan Instruments, Inc. was honored with the International Renowned Brand award at the 9th Shenzhen Brand Week, held from May 9 to 15. The award was approved by the Shenzhen Top Brand Evaluation Committee and the United Nations Industrial Development Organization Centre for South-South Industrial Cooperation (China), marking a new milestone in the company’s three-decade journey of global growth and brand excellence.
As the Shenzhen local special event of China Brand Day (May 10), Shenzhen Brand Week featured nearly 20 themed activities and attracted over one million participants. The event serves as a major platform for advancing brand competitiveness and international visibility among leading enterprises.
At the event, Brand Finance highlighted that over the past decade, Chinese brands have made remarkable strides in global influence, now ranking second worldwide—surpassing Germany and trailing only the United States. This momentum reflects a broader shift in focus among Chinese enterprises toward brand building, technological innovation, and global service excellence. EDAN is proud to be part of this wave, placing long-term value creation, quality, and trust at the heart of its global expansion efforts.
In addition to the International Renowned Brand recognition, EDAN also received the Greater Bay Area Top Brand and Shenzhen Top Brand awards, further underscoring its commitment to innovation, quality, and trust—values that have shaped the company’s development over the past 30 years.
"This recognition is not only a reflection of our global footprint and product excellence but also a testament to the trust our partners and users place in us around the world," said Alex You, Global Marketing Director of EDAN. "Since our founding, we have been committed to bringing innovation and value together to improve the human condition — a mission that has never changed."
Over the past 30 years, EDAN has consistently delivered cutting-edge innovations across multiple disciplines. Its portfolio includes industry-leading technologies in Women’s Care, Cardiology, Monitoring, Sonography, and Blood Gas Analysis — with several product lines ranking top in global and national export. The company also continues to lead in AI-powered diagnostics, cloud-based healthcare platforms, and smart medical solutions, empowering better outcomes in hospitals and remote care settings alike.
Since going public in 2011, EDAN has invested over RMB 2.7 billion in research and development. In 2024 alone, the company allocated approximately RMB 340 million to R&D, accounting for 18.55% of its annual revenue. By the end of 2024, EDAN had secured 1,243 patents, further demonstrating its strong capabilities in independent innovation and intellectual property development.
Receiving this honor during Shenzhen Brand Week, a platform that highlights the city’s best in brand innovation, reinforces EDAN’s role not just as a leader in China’s medical device industry but as a trusted name worldwide.
